223.2 📚 國考版

223.2.0.1 必背 — Lassa Fever

  • ssRNA Arenaviridae
  • W Africa endemic (Nigeria, Sierra Leone, Liberia, Guinea)
  • Mastomys natalensis (multimammate rat) reservoir
  • Transmission: rodent excreta + person-to-person + aerosol + vertical + healthcare
  • 80% mild, 20% severe
  • Severe: fever + facial edema + pharyngitis + bleeding + organ failure
  • SNHL in 30% survivors (often permanent)
  • Pregnancy 3rd trimester: 80%+ mortality
  • Treatment: ribavirin (early start essential) + supportive
  • Vaccines in trials (MVA-LASV, rVSV-Lassa)

223.2.0.2 必背 — LCMV

  • House mouse reservoir
  • Vertical → congenital LCMV (mimics congenital CMV: microcephaly, hydrocephalus, chorioretinitis, calcifications)
  • Transplant transmission = severe multi-organ disease
  • Aseptic meningitis postnatally acquired
  • Treatment: supportive; ribavirin off-label for severe

223.2.0.3 必背 — S. American Hemorrhagic Fevers

  • Junin (Argentine, Calomys musculinus) — Candid #1 vaccine effective
  • Machupo (Bolivian)
  • Guanarito (Venezuelan)
  • Sabia (Brazilian)
  • Treatment: ribavirin + supportive

223.2.0.4 必背 — Ribavirin for Arenaviruses

  • IV regimen for Lassa
  • Early start critical
  • Hemolytic anemia (reversible)
  • Teratogenic (avoid pregnancy except life-threatening)